Literature DB >> 16219722

Modified osteo-odonto-keratoprosthesis for treatment of corneal blindness: long-term anatomical and functional outcomes in 181 cases.

Giancarlo Falcinelli1, Benedetto Falsini, Maurizio Taloni, Paolo Colliardo, Giovanni Falcinelli.   

Abstract

OBJECTIVE: To evaluate long-term anatomical and functional outcomes of a modified osteo-odonto-keratoprosthesis (OOKP) technique for treatment of corneal blindness from various etiologies.
METHODS: Two-hundred three patients (224 eyes) underwent modified OOKP surgery between 1973 and 1999. Of the original cohort, 181 patients (98 men and 83 women; mean [SD], age 54.3 [15] years) in whom a standardized 2-step surgical procedure was performed were included in the study. Preoperative diagnoses were dry eye (n = 70) due to ocular pemphigoid (n = 39), Sjögren syndrome (n = 11), trachoma (n = 8), Lyell syndrome (n = 6), Stevens-Johnson syndrome (n = 4), and graft-vs-host disease (n = 1) and congenital lid coloboma (n = 1), severe corneal burns (n = 68), bullous keratopathy (n = 13), keratitis sequelae (n = 15), and bullous keratopathy secondary to antiglaucoma surgery (n = 15). Several innovations were made to the original Strampelli technique. Median follow-up duration was 12 years (range, 1-25 years).
RESULTS: Anatomical complications leading to OOKP loss were found in 11 (6.07%) of 181 patients. Survival analysis estimated that 18 years after surgery, the probability of retaining an intact OOKP was 85% (95% confidence interval, 79.3%-90.7%). Pooling patient groups, mean (SD) best postoperative visual acuity was 0.76 (0.34). Mean (SD) final acuity at the end of follow-up declined slightly (0.69 [0.39]) but significantly (P<.01). In individual diagnostic groups, mean acuity decline reached statistical significance (P<.05) only in the pemphigoid (1 line), trachoma (1 line), and bullous keratopathy secondary to antiglaucoma surgery (2 lines) groups. Survival analysis estimated that 18 years after surgery, the probability of retaining best postoperative visual acuity (within 2 lines) was mean (SD) 55.5% (12.9%).
CONCLUSION: Modified OOKP surgery for corneal blindness of different etiologies may provide, in the long-term, anatomically stable corneal prosthesis as well as an effective, rehabilitating recovery in visual acuity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16219722     DOI: 10.1001/archopht.123.10.1319

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  36 in total

1.  Cost effectiveness of the type II Boston keratoprosthesis.

Authors:  J D Ament; T P Stryjewski; S Pujari; S Siddique; G N Papaliodis; J Chodosh; C H Dohlman
Journal:  Eye (Lond)       Date:  2010-12-24       Impact factor: 3.775

2.  Long-term functional and anatomical results of osteo- and osteoodonto-keratoprosthesis.

Authors:  Ralph Michael; Victor Charoenrook; Maria Fideliz de la Paz; Wolfgang Hitzl; Jose Temprano; Rafael I Barraquer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-05-20       Impact factor: 3.117

3.  In vivo evaluation of titanium oxide and hydroxyapatite as an artificial cornea skirt.

Authors:  Xiao Wei Tan; Roger W Beuerman; Zhi Long Shi; Koon Gee Neoh; Donald Tan; Khiam Aik Khor; Jodhbir S Mehta
Journal:  J Mater Sci Mater Med       Date:  2012-03-17       Impact factor: 3.896

4.  Structural & functional rehabilitation in eyes with lamina resorption following MOOKP--can the lamina be salvaged?

Authors:  Geetha Iyer; Bhaskar Srinivasan; Shweta Agarwal; Shanmugasundaram Shanmugasundaram; Gunaseelan Rajan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-03-07       Impact factor: 3.117

5.  'On the capability and nomenclature of the Boston Keratoprosthesis type II'.

Authors:  M Zarei-Ghanavati; A Shalaby Bardan; C Liu
Journal:  Eye (Lond)       Date:  2017-12-08       Impact factor: 3.775

6.  [Long-term outcome of keratoprosthesis with biological support].

Authors:  K Hille
Journal:  Ophthalmologe       Date:  2018-01       Impact factor: 1.059

7.  Long-term follow-up of a supradescemetic keratoprosthesis in rabbits: an immunofluorescence study.

Authors:  Edgar M Espana; Ana C Acosta; Josef Stoiber; Viviana Fernandez; Peggy D Lamar; Franck L Villain; Emmanuel Lacombe; Eduardo Alfonso; Jean-Marie Parel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-09-03       Impact factor: 3.117

Review 8.  AlphaCor artificial cornea: clinical outcome.

Authors:  N Jirásková; P Rozsival; M Burova; M Kalfertova
Journal:  Eye (Lond)       Date:  2011-06-17       Impact factor: 3.775

9.  Comprehensive approach to ocular consequences of Stevens Johnson Syndrome - the aftermath of a systemic condition.

Authors:  Geetha Iyer; Bhaskar Srinivasan; Shweta Agarwal; Seema Kamala Muralidharan; Sumathi Arumugam
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-01-29       Impact factor: 3.117

10.  Outcomes with the Boston Type 1 Keratoprosthesis at Instituto de Microcirugía Ocular IMO.

Authors:  Jose L Güell; Edilio Arcos; Oscar Gris; Diego Aristizabal; Miguel Pacheco; Claudia L Sanchez; Felicidad Manero
Journal:  Saudi J Ophthalmol       Date:  2011-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.